Endpoints: "Catalent to cut about 600 jobs in Indiana, Maryland and Texas"

Via Endpoints News, this sad news: 

Contract manufacturing company Catalent is cutting around 600 jobs in Maryland, Texas, and a major manufacturing facility in Bloomington, IN.

According to a report from a local news site, The Bloomingtonian, the manufacturer announced in an email sent out to employees that it will be cutting 400 positions at the Indiana facility. The company will also cut 77 jobs by Jan. 15 of next year at a cell therapy facility in Webster, TX, just outside of Houston. In Maryland, the company is reducing staff at two locations, with 82 jobs being eliminated at Catalent’s facility in Gaithersburg, and 53 in Rockville. The layoffs go into effect at those locations on Jan. 14.

In a statement, Catalent said it had increased its capacities during the Covid-19 pandemic and was now rolling back some of that expansion.

It is surprising to me that Catalent is dialing back its headcount in manufacturing; they must have had a product portfolio that was weighted towards pandemic-related productions and didn't successfully make the transition.

There is a fair bit of talk that there will be a recession in 2023, and I'm genuinely not sure what I think (i.e. how many quarters of negative US GDP growth will there be in 2023? More than 2? Less than 2? Zero? Not sure yet. "More than zero, less than 3" is my safe bet.) I think the market for younger chemists will be fine (not as hot as 2021, but less hot than 2022) and it will not be as good for experienced chemists (less hot than 2021). How to falsify these calculations?")